Female Pelvic Implants Market
Market Insights on Female Pelvic Implants covering sales outlook, demand forecast & up-to-date key trends
Female Pelvic Implants Market By Product Type (Vaginal Mesh Implants, Vaginal Sling, Vaginal Graft Implants), Indication (Pelvic Organ Prolapse, Stress Urinary Incontinence), End User (Hospitals, Ambulatory Surgical Centres, Speciality Clinics) & Region - Forecast to 2021- 2031
Female Pelvic Implants Market Snapshot
The female pelvic implants market will reach a valuation of US$ 245 Mn in 2021, according to the latest Future Market Insights (FMI) analysis. The overall sales outlook remains positive with female pelvic implant demand forecast to total US$ 322.6 Mn by 2031, as the market continues to exhibit growth at a CAGR of 2.8% between 2021 and 2031.
As per FMI, the top five players comprising Johnson & Johnson, Coloplast A/S, Becton, Dickinson and Company, Boston Scientific Corporation, and Cook Medical constitutes around 75% of the overall market.
Let us know your requirement to get
100% FREE customization
Key Points Covered in Female Pelvic Implants Market Study
- Market estimates and forecast 2016-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Female Pelvic Implants Market and How to Navigate
- Recommendation on Key Winning Strategies
2016-2020 Female Pelvic Implants Market Outlook Compared to 2021-2031 Forecast
According to Future Market Insights (FMI), the demand for female pelvic implants has grown at a 2.5% CAGR between 2016 and 2020. According to the Division of Female Pelvic Medicine and Reconstructive Surgery in the Northwestern University Chicago, women with normal life expectancy have an average 30–50% chance of developing pelvic organ prolapse.
Approximately 19% of these women need to undergo at least one surgical intervention for POP or SUI and 30% of them undergo reoperation for recurrence. Despite such high prevalence, there is no definite cure or restoration of anatomical defects for pelvic organ prolapse or stress urinary incontinence. Over the past two decades, attempts have been made to improve the outcomes of surgery.
However, the majority of such efforts have resulted in the use of vaginal mesh and grafts. So far, surgical options with mesh implants and slings are proving to be the best option for such disorders which imply a heavy social and economic burden. Other surgical options such as allografts and xenografts are costly and carry the potential of transmission of infectious disease and synthetic meshes.
Thus, the market for female pelvic implants is expected to see continuous growth in the use of mesh and sling implants until definite alternatives are available for these products.
Future Market Insights expects the global female pelvic implants market to rise at 2.8% CAGR between 2021 and 2031.
How will the Market Gain from Novel Tissue Engineering Launch for Female Pelvic Floor Reconstruction?
Ongoing post-marketing surveillance of approved devices and the introduction of novel tissue engineering in female pelvic floor reconstruction creates huge opportunities in the female pelvic implants market. The majority of manufacturers are selling their products in the global market despite strict regulations.
After Food and Drug Administration (FDA) reclassification of vaginal mesh implants from Class II to Class III medical devices, the FDA has advised 33 manufacturers to conduct 3-year studies to assess the impact of organ damage and other complications of mesh implants. After assessing the risks, the manufacturers can reintroduce their devices and can get pre-market approval from the FDA.
This allows manufacturers to re-launch mesh implants, which is expected to enter the market by 2022. Similarly, the introduction of novel tissue engineering with growth factors, biomaterials, and drugs implanted into tissue damage or loss is set to boost repair time, stimulating the regeneration of damaged tissue.
Studies initiating tissue engineering for pelvic organ prolapse have reported the use of novel designed knit material fabricated from FDA?approved non-degradable polyamide dip?coated in gelatin for MSC seeding and delivery. Polypropylene mesh commonly used in clinical practice has good mechanical properties, but there are long?term complications. This validates the need for tissue engineering technology in the treatment of pelvic organ prolapse and promotes an innovative approach to pelvic implantation.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining Demand for Female Pelvic Implants?
As per the USFDA, the transvaginal placement of surgical mesh can be risky in women with POP mesh complications. Some of the common complications reported include mesh erosion, infections, vaginal scarring, discomfort and pain during sex, and even resurgence of urinary incontinence.
Through January 31, 2019, over 139,000 adverse events have been reported for mesh products of which over 69,000 events were reported for POP mesh products, as per FDA, 2020. This restricts the patients from taking surgeries to implant vaginal mesh, thereby deterring market growth. This growing awareness towards surgical complications is curbing patients from opting for vaginal mesh implants in the high growth markets of Europe and the U.S.
What is the impact of the COVID-19 Crisis on the Female Pelvic Implants Market?
There are several long-term and short-term impacts on the industry caused by the COVID-19 crisis. Some industries have shown no impact on their sales while some have been adversely hit. The medical device industry is hampered due to supply chain disruption in the 1st quarter of 2020.
The global female pelvic implants market is affected to an extent due to supply chain disruption. The sale of female pelvic implants has slumped due to the cancellation of elective surgeries and procedures.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Insights
How is the Female Pelvic Implants Market Faring in the U.S?
The U.S. holds over 83% share of the female pelvic implants market in North America. According to the Association for Pelvic Organ Prolapse Support, about 34 million women suffer from pelvic organ prolapse (POP) across the globe currently.
In the U.S., the total number of patients with POP is 3.3 million. According to the National Association for Incontinence, 25 million peoples in the U.S. suffer from some form of urinary incontinence, out of which 75% are women. Stress urinary incontinence (SUI) is the most prevalent form.
In the U.S., approximately 15 million people are suffering from SUI. Thus, the rising prevalence of pelvic organ prolapse and stress urinary incontinence is driving the U.S. female pelvic implants market.
How is Support for Women Post-Operation Driving Demand for Female Pelvic Implants in the U.K.?
The U.K. market accounts for over 13% of the Europe market through the assessment period ending in 2031. The governments of various countries of Europe like the U.K. are forming committees that can address the issues of women suffering from peri-operative complications of surgeries for pelvic implants. These programs are expected to raise awareness among the patients, hospitals, and GPs and can increase the penetration of female pelvic implants over the forecast period.
For instance, hospitals in the U.K are forming a multidisciplinary team (MDT) consisting of specialists from urogynecology, urology, radiology, pain management, and more, to provide advice and treatment. This MDT assesses complications and advises the patient if surgery to treat mesh complications is needed.
What is the Scope of Growth of Female Pelvic Implants Sales in the India Market?
The India market accounts for more than 30% of the sales registered in South Asia in 2021. Most developing countries have patients that are not aware of conditions such as pelvic organ prolapse and stress urinary incontinence.
Perception of pain associated with surgery evokes considerable anxiety in patients resulting in reluctance to consider surgical options to cure SUI or POP. Many women delay or do not seek treatment for these diseases in India due to a lack of awareness, which is foreseen to be the biggest challenge for the growth of female pelvic implants in the Indian market.
What Factors are Driving Revenue Generation in the Australia market?
The market for female pelvic Implants in Australia is exhibiting a 2.8% CAGR and is projected to account for more than 86% of the Oceania market throughout the projection period. Growing government initiatives to create awareness is anticipated to boost growth in the region.
For instance, the Australian government has developed the Continence Aids Payment Scheme (CAPS) to support patients with severe incontinence problems. Furthermore, professionals, such as urologists, urogynecologists, gynecologists, nurses, and other skilled organizations have actively promoted awareness of urinary continence in all care settings.
A growing number of awareness programs, regarding pelvic floor diseases and the increasing incidence of urinary incontinence (UI), by different government and non-profit organizations are fueling growth.
Category-wise Insights
Why are Vaginal Sling/Tapes Key to Revenue Generation?
Vaginal sling/tapes have a higher potential for growth. The segment is likely to grow with a relatively high CAGR of 2.5% in the near future. Vaginal sling/tape implants are generally made from a narrow ‘tape’ of polypropylene mesh which is placed under the urethra like a sling or hammock to keep the urethra in the correct position.
Vaginal slings have been in the market for about 20 years and can be implanted in half-hour. The minimally invasive surgical procedure under local anesthesia is preferred for outpatient applications. Owing to these advantages, demand for vaginal sling/tapes is increasing during the forecast period.
Will Stress Urinary Incontinence (SUI) Continue Fuelling Female Pelvic Implants Demand?
The stress urinary incontinence (SUI) segment is expected to contribute maximum revenue share in the global female pelvic implants market. In terms of revenue, the stress urinary incontinence (SUI) segment accounts for around over 58% share in 2021.
The demand for female pelvic implants is likely to witness strong growth on account of the prevalence of stress urinary incontinence and rising awareness among women regarding treatment options on a global scale.
What is the Scope of Sales across Hospitals?
Hospitals are currently the leading end users of female pelvic implants with a 2.2% CAGR through the forecast period. Similarly, hospitals can impact higher investment abilities and capital, with the surge in the number of emergency admissions, which will enhance growth prospects for the long term.
Competitive Landscape
Manufacturers are primarily focusing on developing new products to bolster the acceptance of female pelvic implants, thus anticipating the surge in sales figures. The companies are focusing on outsourcing the production of female pelvic implants to reduce manufacturing costs, thereby challenging the market with reduced costs. Key players are entering into collaborations, partnerships, mergers and acquisitions to expand their product portfolio and global market.
- Coloplast acquired Nine Continents Medical, Inc. in November 2020 and aimed to expand its medical device product portfolio.
- Betatech Medical participated in Expomed 2018 which was held in Istanbul on the 28th of February. Betatech developed uterine and pelvic surgical slings and mesh.
- In August 2020, InterStim announced the receipt of FDA approval for its Micro neurostimulator and SureScan MRI for non-obstructive urinary retention, overactive bladder, and fecal incontinence.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Value in Million |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa |
|
Key Countries Covered |
US, Canada, U.K., Germany, Italy, France, Spain, Benelux, Russia, India, Thailand, Malaysia, Indonesia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, Turkey, South Africa and North Africa |
|
Key Segments Covered |
Product Type, Indication, End-User, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Market Taxonomy
Product Type:
- Vaginal Mesh Implants
- Vaginal Sling
- Vaginal Graft Implants
Indication:
- Pelvic Organ Prolapse
- Stress Urinary Incontinence
End User:
- Hospitals
- Ambulatory Surgical Centres
- Speciality Clinics
Region:
- North America
- Latin America
- China
- Western Europe
- Eastern Europe
- APECJ
- Japan
- MEA
Frequently Asked Questions
The female pelvic implants market is predicted to grow at 2.8% CAGR through 2032.
North America female pelvic implants market holds the highest revenue potential, with US holding 83% of the market share.
The female pelvic implants market is expected to surpass US$ 331.96 Mn by 2032.
The female pelvic implants market size is anticipated to be over US$ 251.86 Mn in 2022.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
3.3. Product USPs / Features
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Per Capita Healthcare Expenditure Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. New Product Launches
4.2.2. Product Cost and Features
4.2.3. Product Availability
4.2.4. Rising Prevalence of Pelvic Organ Prolapse
4.3. Value Chain
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Statistics and Probable Future Impact
5.2. Current Economic Projection as compared to 2008 financial analysis
5.3. COVID19 and Impact Analysis
5.3.1. Revenue By Product Type
5.3.2. Revenue By Indication
5.3.3. Revenue By End User
5.4. Revenue By Country
6. Key Success Factors
6.1. Key Industry developments
6.2. Product Adoption / Usage Analysis
6.3. Key Strategies Followed By Manufacturers
6.4. Regulatory Scenario
6.5. Reimbursement Scenario
6.6. Product History And Recalls
7. Global Female Pelvic Implants Market Volume Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Volume Analysis, 2016-2020
7.2. Current and Future Market Volume Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Female Pelvic Implants Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product Type
8.2. Pricing Assumptions
9. Global Female Pelvic Implants Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031, by Product Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2016-2020
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2021-2031
10.3.1. Vaginal Mesh Implants
10.3.2. Vaginal Sling/Tape
10.3.3. Vaginal Graft Implants
10.4. Market Attractiveness Analysis By Product Type
11. Global Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031, By Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By Indication, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2021-2031
11.3.1. Pelvic Organ Prolapse (POP)
11.3.2. Stress Urinary Incontinence (SUI)
11.4. Market Attractiveness Analysis By Indication
12. Global Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Specialty Clinics
12.4. Market Attractiveness Analysis By End User
13. Global Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021- 2031
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product Type
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Latin America Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product Type
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Europe Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product Type
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product Type
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. East Asia Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product Type
18.3.3. By Indication
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Oceania Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product Type
19.3.3. By Indication
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Product Type
20.3.3. By Indication
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Key and Emerging Countries Female Pelvic Implants Market Analysis 2016-2020 and Forecast 2021-2031
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Female Pelvic Implants Market Analysis
21.2.1. By Product Type
21.2.2. By Indication
21.2.3. By End User
21.3. Canada Female Pelvic Implants Market Analysis
21.3.1. By Product Type
21.3.2. By Indication
21.3.3. By End User
21.4. Mexico Female Pelvic Implants Market Analysis
21.4.1. By Product Type
21.4.2. By Indication
21.4.3. By End User
21.5. Brazil Female Pelvic Implants Market Analysis
21.5.1. By Product Type
21.5.2. By Indication
21.5.3. By End User
21.6. U.K. Female Pelvic Implants Market Analysis
21.6.1. By Product Type
21.6.2. By Indication
21.6.3. By End User
21.7. Germany Female Pelvic Implants Market Analysis
21.7.1. By Product Type
21.7.2. By Indication
21.7.3. By End User
21.8. France Female Pelvic Implants Market Analysis
21.8.1. By Product Type
21.8.2. By Indication
21.8.3. By End User
21.9. Italy Female Pelvic Implants Market Analysis
21.9.1. By Product Type
21.9.2. By Indication
21.9.3. By End User
21.10. Spain Female Pelvic Implants Market Analysis
21.10.1. By Product Type
21.10.2. By Indication
21.10.3. By End User
21.11. BENELUX Female Pelvic Implants Market Analysis
21.11.1. By Product Type
21.11.2. By Indication
21.11.3. By End User
21.12. Russia Female Pelvic Implants Market Analysis
21.12.1. By Product Type
21.12.2. By Indication
21.12.3. By End User
21.13. China Female Pelvic Implants Market Analysis
21.13.1. By Product Type
21.13.2. By Indication
21.13.3. By End User
21.14. Japan Female Pelvic Implants Market Analysis
21.14.1. By Product Type
21.14.2. By Indication
21.14.3. By End User
21.15. South Korea Female Pelvic Implants Market Analysis
21.15.1. By Product Type
21.15.2. By Indication
21.15.3. By End User
21.16. India Female Pelvic Implants Market Analysis
21.16.1. By Product Type
21.16.2. By Indication
21.16.3. By End User
21.17. Australia Female Pelvic Implants Market Analysis
21.17.1. By Product Type
21.17.2. By Indication
21.17.3. By End User
21.18. New Zealand Female Pelvic Implants Market Analysis
21.18.1. By Product Type
21.18.2. By Indication
21.18.3. By End User
21.19. GCC Countries Female Pelvic Implants Market Analysis
21.19.1. By Product Type
21.19.2. By Indication
21.19.3. By End User
21.20. Turkey Female Pelvic Implants Market Analysis
21.20.1. By Product Type
21.20.2. By Indication
21.20.3. By End User
21.21. South Africa Female Pelvic Implants Market Analysis
21.21.1. By Product Type
21.21.2. By Indication
21.21.3. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Concentration
22.4. Market Presence Analysis
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive (Tentative List)
23.3.1. Johnson & Johnson
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Sales Footprint
23.3.1.4. Key Financials
23.3.1.5. Strategic overview
23.3.2. Boston Scientific Corporation
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Sales Footprint
23.3.2.4. Key Financials
23.3.2.5. Strategic overview
23.3.3. Coloplast A/S
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Sales Footprint
23.3.3.4. Key Financials
23.3.3.5. Strategic overview
23.3.4. Betatech Medical
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Sales Footprint
23.3.4.4. Key Financials
23.3.4.5. Strategic overview
23.3.5. pfm medical ag
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Sales Footprint
23.3.5.4. Key Financials
23.3.5.5. Strategic overview
23.3.6. PROMEDON GmbH
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Sales Footprint
23.3.6.4. Key Financials
23.3.6.5. Strategic overview
23.3.7. Dipromed Srl
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Sales Footprint
23.3.7.4. Key Financials
23.3.7.5. Strategic overview
23.3.8. Cook Medical
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Sales Footprint
23.3.8.4. Key Financials
23.3.8.5. Strategic overview
23.3.9. Caldera Medical
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Sales Footprint
23.3.9.4. Key Financials
23.3.9.5. Strategic overview
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Female Pelvic Implants Market Volume (in Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 02: Global Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 03: Global Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 04: Global Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 05: Global Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 06: North America Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 07: North America Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 08: North America Female Pelvic Implants Market Volume (in Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 09: North America Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 10: North America Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 11: Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 12: Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 13: Latin America Female Pelvic Implants Market Volume (in Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 14: Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 15: Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 16: Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 17: Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 18: Europe Female Pelvic Implants Market Volume (in Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 19: Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 20: Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 21: South Asia Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 22: South Asia Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 23: South Asia Female Pelvic Implants Market Volume (in Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 24: South Asia Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 25: South Asia Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 26: East Asia Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 27: East Asia Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 28: East Asia Female Pelvic Implants Market Volume (in Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 29: East Asia Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 30: East Asia Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 31: Oceania Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 32: Oceania Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 33: Oceania Female Pelvic Implants Market Volume (in Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 34: Oceania Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 35: Oceania Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 36: MEA Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 37: MEA Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 38: MEA Female Pelvic Implants Market Volume (in Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
Table 39: MEA Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 40: MEA Female Pelvic Implants Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Female Pelvic Implants Market Value Share By Product Type (2021 E)
Figure 02: Global Female Pelvic Implants Market Value Share By Indication (2021 E)
Figure 03: Global Female Pelvic Implants Market Value Share By End User (2021 E)
Figure 04: Global Female Pelvic Implants Market Value Share By Region (2021 E)
Figure 05: Global Female Pelvic Implants Market Volume (in Units) Analysis, 2016-2020
Figure 06: Global Female Pelvic Implants Market Volume (in Units) & Y-o-Y Growth (%) Analysis, 2021-2031
Figure 07: Global Female Pelvic Implants Historical Market Size and Y-o-Y, 2016 - 2020
Figure 08: Global Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 09: Global Female Pelvic Implants Market Absolute $ Opportunity, 2016–2031
Figure 10: Global Female Pelvic Implants Market Attractiveness Analysis, By Product Type
Figure 11: Global Female Pelvic Implants Market Attractiveness Analysis, By Indication
Figure 12: Global Female Pelvic Implants Market Attractiveness Analysis, By End User
Figure 13: Global Female Pelvic Implants Market Attractiveness Analysis, By Region
Figure 14: North America Female Pelvic Implants Market Share, By Product Type (2021)
Figure 15: North America Female Pelvic Implants Market Share, By Indication (2021)
Figure 16: North America Female Pelvic Implants Market size (US$ Mn) 2021 & 2031
Figure 17: North America Female Pelvic Implants Market Share, By End User (2021)
Figure 18: North America Female Pelvic Implants Market Share, By Country (2021)
Figure 19: North America Female Pelvic Implants Market Size (US$ Mn) Analysis, 2016–2020,
Figure 20: North America Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 21: North America Female Pelvic Implants Market Attractiveness Analysis, By Country
Figure 22: North America Female Pelvic Implants Market Attractiveness Analysis, By Product Type
Figure 23: North America Female Pelvic Implants Market Attractiveness Analysis, By Indication
Figure 24: North America Female Pelvic Implants Market Attractiveness Analysis, By End User
Figure 25: Latin America Female Pelvic Implants Market Share, By Product Type (2021)
Figure 26: Latin America Female Pelvic Implants Market Share, By Indication (2021)
Figure 27: Latin America Female Pelvic Implants Market size (US$ Mn) 2021 & 2031
Figure 28: Latin America Female Pelvic Implants Market Share, By End User (2021)
Figure 29: Latin America Female Pelvic Implants Market Share, By Country (2021)
Figure 30: Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis, 2016–2020,
Figure 31: Latin America Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 32: Latin America Female Pelvic Implants Market Attractiveness Analysis, By Country
Figure 33: Latin America Female Pelvic Implants Market Attractiveness Analysis, By Product Type
Figure 34: Latin America Female Pelvic Implants Market Attractiveness Analysis, By Indication
Figure 35: Latin America Female Pelvic Implants Market Attractiveness Analysis, By End User
Figure 36: Europe Female Pelvic Implants Market Share, By Product Type (2021)
Figure 37: Europe Female Pelvic Implants Market Share, By Indication (2021)
Figure 38: Europe Female Pelvic Implants Market size (US$ Mn) 2021 & 2031
Figure 39: Europe Female Pelvic Implants Market Share, By End User (2021)
Figure 40: Europe Female Pelvic Implants Market Share, By Country (2021)
Figure 41: Europe Female Pelvic Implants Market Size (US$ Mn) Analysis, 2016–2020,
Figure 42: Europe Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 43: Europe Female Pelvic Implants Market Attractiveness Analysis, By Country
Figure 44: Europe Female Pelvic Implants Market Attractiveness Analysis, By Product Type
Figure 45: Europe Female Pelvic Implants Market Attractiveness Analysis, By Indication
Figure 46: Europe Female Pelvic Implants Market Attractiveness Analysis, By End User
Figure 47: South Asia Female Pelvic Implants Market Share, By Product Type (2021)
Figure 48: South Asia Female Pelvic Implants Market Share, By Indication (2021)
Figure 49: South Asia Female Pelvic Implants Market size (US$ Mn) 2021 & 2031
Figure 50: South Asia Female Pelvic Implants Market Share, By End User (2021)
Figure 51: South Asia Female Pelvic Implants Market Share, By Country (2021)
Figure 52: South Asia Female Pelvic Implants Market Size (US$ Mn) Analysis, 2016–2020,
Figure 53: South Asia Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 54: South Asia Female Pelvic Implants Market Attractiveness Analysis, By Country
Figure 55: South Asia Female Pelvic Implants Market Attractiveness Analysis, By Product Type
Figure 56: South Asia Female Pelvic Implants Market Attractiveness Analysis, By Indication
Figure 57: South Asia Female Pelvic Implants Market Attractiveness Analysis, By End User
Figure 58: East Asia Female Pelvic Implants Market Share, By Product Type (2021)
Figure 59: East Asia Female Pelvic Implants Market Share, By Indication (2021)
Figure 60: East Asia Female Pelvic Implants Market size (US$ Mn) 2021 & 2031
Figure 61: East Asia Female Pelvic Implants Market Share, By End User (2021)
Figure 62: East Asia Female Pelvic Implants Market Share, By Country (2021)
Figure 63: South Asia Female Pelvic Implants Market Size (US$ Mn) Analysis, 2016–2020,
Figure 64: South Asia Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 65: East Asia Female Pelvic Implants Market Attractiveness Analysis, By Country
Figure 66: East Asia Female Pelvic Implants Market Attractiveness Analysis, By Product Type
Figure 67: East Asia Female Pelvic Implants Market Attractiveness Analysis, By Indication
Figure 68: East Asia Female Pelvic Implants Market Attractiveness Analysis, By End User
Figure 69: Oceania Female Pelvic Implants Market Share, By Product Type (2021)
Figure 70: Oceania Female Pelvic Implants Market Share, By Indication (2021)
Figure 71: Oceania Female Pelvic Implants Market size (US$ Mn) 2021 & 2031
Figure 72: Oceania Female Pelvic Implants Market Share, By End User (2021)
Figure 73: Oceania Female Pelvic Implants Market Share, By Country (2021)
Figure 74: Oceania Female Pelvic Implants Market Size (US$ Mn) Analysis, 2016–2020,
Figure 75: Oceania Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 76: Oceania Female Pelvic Implants Market Attractiveness Analysis, By Country
Figure 77: Oceania Female Pelvic Implants Market Attractiveness Analysis, By Product Type
Figure 78: Oceania Female Pelvic Implants Market Attractiveness Analysis, By Indication
Figure 79: Oceania Female Pelvic Implants Market Attractiveness Analysis, By End User
Figure 80: MEA Female Pelvic Implants Market Share, By Product Type (2021)
Figure 81: MEA Female Pelvic Implants Market Share, By Indication (2021)
Figure 82: MEA Female Pelvic Implants Market size (US$ Mn) 2021 & 2031
Figure 83: MEA Female Pelvic Implants Market Share, By End User (2021)
Figure 84: MEA Female Pelvic Implants Market Share, By Country (2021)
Figure 85: MEA Female Pelvic Implants Market Size (US$ Mn) Analysis, 2016–2020,
Figure 86: MEA Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 87: MEA Female Pelvic Implants Market Attractiveness Analysis, By Country
Figure 88: MEA Female Pelvic Implants Market Attractiveness Analysis, By Product Type
Figure 89: MEA Female Pelvic Implants Market Attractiveness Analysis, By Indication
Figure 90: MEA Female Pelvic Implants Market Attractiveness Analysis, By End User
Figure 91: U.S. Market Value Proportion Analysis
Figure 92: Global Vs U.S. Growth Comparison
Figure 93: U.S. Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 94: U.S. Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 95: U.S. Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 96: Canada Market Value Proportion Analysis
Figure 97: Global Vs Canada Growth Comparison
Figure 98: Canada Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 99: Canada Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 100: Canada Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 101: Brazil Market Value Proportion Analysis
Figure 102: Global Vs Brazil Growth Comparison
Figure 103: Brazil Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 104: Brazil Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 105: Brazil Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 106: Mexico Market Value Proportion Analysis
Figure 107: Global Vs Mexico Growth Comparison
Figure 108: Mexico Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 109: Mexico Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 110: Mexico Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 111: U.K. Market Value Proportion Analysis
Figure 112: Global Vs U.K. Growth Comparison
Figure 113: U.K. Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 114: U.K. Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 115: U.K. Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 116: Germany Market Value Proportion Analysis
Figure 117: Global Vs Germany Growth Comparison
Figure 118: Germany Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 119: Germany Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 120: Germany Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 121: Italy Market Value Proportion Analysis
Figure 122: Global Vs Italy Growth Comparison
Figure 123: Italy Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 124: Italy Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 125: Italy Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 126: France Market Value Proportion Analysis
Figure 127: Global Vs France Growth Comparison
Figure 128: France Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 129: France Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 130: France Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 131: Spain Market Value Proportion Analysis
Figure 132: Global Vs Spain Growth Comparison
Figure 133: Spain Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 134: Spain Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 135: Spain Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 136: BENELUX Market Value Proportion Analysis
Figure 137: Global Vs BENELUX Growth Comparison
Figure 138: BENELUX Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 139: BENELUX Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 140: BENELUX Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 141: Russia Market Value Proportion Analysis
Figure 142: Global Vs Russia Growth Comparison
Figure 143: Russia Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 144: Russia Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 145: Russia Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 146: India Market Value Proportion Analysis
Figure 147: Global Vs India Growth Comparison
Figure 148: India Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 149: India Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 150: India Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 151: Thailand Market Value Proportion Analysis
Figure 152: Global Vs Thailand Growth Comparison
Figure 153: Thailand Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 154: Thailand Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 155: Thailand Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 156: Malaysia Market Value Proportion Analysis
Figure 157: Global Vs Malaysia Growth Comparison
Figure 158: Malaysia Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 159: Malaysia Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 160: Malaysia Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 161: Indonesia Market Value Proportion Analysis
Figure 162: Global Vs Indonesia Growth Comparison
Figure 163: Indonesia Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 164: Indonesia Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 165: Indonesia Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 166: China Market Value Proportion Analysis
Figure 167: Global Vs China Growth Comparison
Figure 168: China Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 169: China Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 170: China Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 171: Japan Market Value Proportion Analysis
Figure 172: Global Vs Japan Growth Comparison
Figure 173: Japan Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 174: Japan Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 175: Japan Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 176: South Korea Market Value Proportion Analysis
Figure 177: Global Vs South Korea Growth Comparison
Figure 178: South Korea Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 179: South Korea Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 180: South Korea Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 181: Australia Market Value Proportion Analysis
Figure 182: Global Vs Australia Growth Comparison
Figure 183: Australia Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 184: Australia Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 185: Australia Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 186: New Zealand Market Value Proportion Analysis
Figure 187: Global Vs New Zealand Growth Comparison
Figure 188: New Zealand Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 189: New Zealand Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 190: New Zealand Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 191: Turkey Market Value Proportion Analysis
Figure 192: Global Vs Turkey Growth Comparison
Figure 193: Turkey Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 194: Turkey Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 195: Turkey Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 196: GCC Countries Market Value Proportion Analysis
Figure 197: Global Vs GCC Countries Growth Comparison
Figure 198: GCC Countries Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 199: GCC Countries Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 200: GCC Countries Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Figure 201: South Africa Market Value Proportion Analysis
Figure 202: Global Vs South Africa Growth Comparison
Figure 203: South Africa Female Pelvic Implants Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 204: South Africa Female Pelvic Implants Market Share Analysis (%) By Indication, 2021 & 2031
Figure 205: South Africa Female Pelvic Implants Market Share Analysis (%) By End User, 2021 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
